These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38214579)

  • 1. Borneol-Modified Schisandrin B Micelles Cross the Blood-Brain Barrier To Treat Alzheimer's Disease in Aged Mice.
    Li FR; Yu Y; Du YM; Kong L; Liu Y; Wang JH; Chen MH; Liu M; Zhang ZX; Li XT; Ju RJ
    ACS Chem Neurosci; 2024 Feb; 15(3):593-607. PubMed ID: 38214579
    [No Abstract]   [Full Text] [Related]  

  • 2. Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating.
    Guo X; Wu G; Wang H; Chen L
    J Pharm Sci; 2019 May; 108(5):1726-1735. PubMed ID: 30537472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borneol-modified docetaxel plus tetrandrine micelles for treatment of drug-resistant brain glioma.
    Liu Y; Cai JY; Liu Y; Zhang L; Guo RB; Li XT; Ma LY; Kong L
    Drug Dev Ind Pharm; 2024 Feb; 50(2):135-149. PubMed ID: 38235554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
    Qi Y; Cheng X; Jing H; Yan T; Xiao F; Wu B; Bi K; Jia Y
    Metab Brain Dis; 2019 Dec; 34(6):1689-1703. PubMed ID: 31422511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in streptozotocin (STZ)-induced Alzheimer's disease rats.
    Song L; Piao Z; Yao L; Zhang L; Lu Y
    Exp Anim; 2020 Aug; 69(3):363-373. PubMed ID: 32336744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells.
    Song JX; Lin X; Wong RN; Sze SC; Tong Y; Shaw PC; Zhang YB
    Phytother Res; 2011 Mar; 25(3):435-43. PubMed ID: 20740476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.
    Guo M; An F; Yu H; Wei X; Hong M; Lu Y
    Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease.
    Sun J; Wei C; Liu Y; Xie W; Xu M; Zhou H; Liu J
    Biomaterials; 2019 Mar; 197():417-431. PubMed ID: 30638753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizandrin A ameliorates cognitive functions via modulating microglial polarisation in Alzheimer's disease mice.
    Wang Q; Liu L; Guan H; Zhou Y; Li Q
    Pharm Biol; 2021 Dec; 59(1):860-867. PubMed ID: 34214019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schisandrin B alleviates acute oxidative stress via modulation of the Nrf2/Keap1-mediated antioxidant pathway.
    Wu Y; Li ZC; Yao LQ; Li M; Tang M
    Appl Physiol Nutr Metab; 2019 Jan; 44(1):1-6. PubMed ID: 29742356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.
    Zhang QL; Fu BM; Zhang ZJ
    Drug Deliv; 2017 Nov; 24(1):1037-1044. PubMed ID: 28687052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice.
    Ip SP; Yiu HY; Ko KM
    Mol Cell Biochem; 2000 Feb; 205(1-2):111-4. PubMed ID: 10821428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo.
    Zhu S; Wang Y; Chen M; Jin J; Qiu Y; Huang M; Huang Z
    Am J Chin Med; 2012; 40(3):551-66. PubMed ID: 22745070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression.
    Giridharan VV; Thandavarayan RA; Arumugam S; Mizuno M; Nawa H; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
    PLoS One; 2015; 10(11):e0142483. PubMed ID: 26556721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
    Shao M; Yang W; Han G
    Int J Nanomedicine; 2017; 12():7121-7130. PubMed ID: 29026305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
    Thandavarayan RA; Giridharan VV; Arumugam S; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
    PLoS One; 2015; 10(3):e0119214. PubMed ID: 25742619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer's disease-related symptoms in APP/PS-1 mice.
    Zhang X; Shi N; Chen M; Liu M; Ju R; Liu Y; Kong L; Yu Y; Li X
    J Drug Target; 2023 Jul; 31(6):634-645. PubMed ID: 37203195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schisandrin B regulates lipid metabolism in subcutaneous adipocytes.
    Kwan HY; Wu J; Su T; Chao XJ; Yu H; Liu B; Fu X; Tse AKW; Chan CL; Fong WF; Yu ZL
    Sci Rep; 2017 Aug; 7(1):10266. PubMed ID: 28860616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer's Disease: Stereochemistry and Biological Activity.
    Hu XL; Guo C; Hou JQ; Feng JH; Zhang XQ; Xiong F; Ye WC; Wang H
    ACS Chem Neurosci; 2019 Feb; 10(2):996-1007. PubMed ID: 29944335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
    Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
    Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.